share_log

Takeda Pharmaceutical | 6-K: Quarterly Securities Report For The Nine-month Period and Three-month Quarter Ended December 31, 2023

SEC announcement ·  Feb 2 06:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more